Author: Alshaya, Omar A.; Saleh, Rana A.; Alshehri, Shaden D.
Title: Voriconazole-Induced Hepatotoxicity Resolved after Switching to Amphotericin B in Fusarium dimerum Central Line-Associated Bloodstream Infection Cord-id: xz0or5tp Document date: 2021_8_10
ID: xz0or5tp
Snippet: Patient: Female, 38-year-old Final Diagnosis: Drug induced liver injury Symptoms: Fever • abdominal pain • nausea and vomiting • loose stools Medication: — Clinical Procedure: — Specialty: Infectious Diseases • General and Internal Medicine • Pharmacology and Pharmacy OBJECTIVE: Rare disease BACKGROUND: Fusarium spp. is a rare cause of opportunistic life-threatening fungal infections. It has a remarkably high resistance profile with few effective antifungal agents, mostly limited t
Document: Patient: Female, 38-year-old Final Diagnosis: Drug induced liver injury Symptoms: Fever • abdominal pain • nausea and vomiting • loose stools Medication: — Clinical Procedure: — Specialty: Infectious Diseases • General and Internal Medicine • Pharmacology and Pharmacy OBJECTIVE: Rare disease BACKGROUND: Fusarium spp. is a rare cause of opportunistic life-threatening fungal infections. It has a remarkably high resistance profile with few effective antifungal agents, mostly limited to voriconazole and liposomal amphotericin B. Drug-induced liver injury (DILI) by 1 of these 2 antifungal agents further complicates the management of these infections. CASE REPORT: A 38-year-old woman with short bowel syndrome presented to the hospital with concerns of abdominal pain and loose stools. An abdominal CT was negative for inflammatory or ischemic bowel disease, and there was no evidence of liver disease. She tested positive for SARS-CoV-2 and required transfer to the ICU due to hypotension requiring fluid resuscitation and vasopressors. On day 43 of her admission, the patient developed a low-grade fever, for which she underwent central-line and peripheral-blood cultures that were positive for Fusarium dimerum. The central line was removed and i.v. voriconazole was started. After 3 days of treatment, the patient’s liver enzymes rose abruptly. Voriconazole was discontinued and replaced with liposomal amphotericin B, and the liver enzymes improved significantly. The patient completed 14 days of therapy and was discharged from the hospital. CONCLUSIONS: This is a case of F. dimerum infection followed by DILI from voriconazole treatment. Her infection was resolved after switching to liposomal amphotericin B, with improvement in liver enzymes on day 1 after discontinuing voriconazole. This observation demonstrates that altering antifungal classes may be an appropriate strategy when confronted with DILI.
Search related documents:
Co phrase search for related documents- abdominal ct and liver disease: 1, 2
- abdominal ct and liver enzyme: 1
- abdominal ct and liver function: 1, 2, 3
- abdominal ct and liver function test: 1
- abdominal ct and liver injury: 1, 2, 3
- abdominal pain and admission 10 day: 1
- abdominal pain and liver damage: 1, 2, 3, 4, 5, 6, 7, 8
- abdominal pain and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- abdominal pain and liver enzyme: 1, 2, 3, 4, 5, 6, 7, 8
- abdominal pain and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- abdominal pain and liver function test: 1
- abdominal pain and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- abdominal pain and liver transaminase: 1, 2
- abdominal pain and low grade fever: 1, 2, 3
- admission 10 day and liver damage: 1
- admission 10 day and liver injury: 1
- liver disease and low grade fever: 1
- liver enzyme and low grade fever: 1
- liver function and low grade fever: 1
Co phrase search for related documents, hyperlinks ordered by date